WikiSWOT.com :: Free Abbott Laboratories SWOT Analysis

Pharmaceuticals & Biotech >> Abbott Laboratories SWOT Analysis:

Strengths Global presence Impressive growth forecast for Humira across a wide range of autoimmune disorders Robust lipid management portfolio supported by a range of pipeline programs Strong record of lifecycle management crucial in view of forthcoming patent expires Innovation leader in the industry	Weaknesses Upcoming patent expires Narrow phase III pipeline, with little in the way of explosive launch opportunities Late-stage pipeline currently offers limited expansion beyond existing therapeutic positions
Opportunities License agreements Launch of Flutiform Positive outlook for diagnostics market	Threats Unprecedented generic erosion exacerbated by ineffective product lifecycle launches Government regulation Industry consolidation

History: Version 9 (Newest), Version 8, Version 7, Version 6, Version 5, Version 4, Version 3, Version 2, Version 1 (Oldest)

Go back to the SWOT analysis index, or start a discussion about Abbott Laboratories SWOT analysis by adding a comment below WikiSWOT Comments

Name
Email (not shared)
Website

Add comment